30 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Aldeyra Therapeutics, Inc. ALDX shares gained 46.4 percent to $14.495 after announcing positive Phase 2b results for its topical ocular reproxalap in patients with dry eye disease.
• India Globalization Capital, Inc. IGC shares climbed 28.8 percent to $3.00 after the company late Tuesday won an agreement for global rights to develop CBD-infused drinks.
• Onconova Therapeutics, Inc. ONTX gained 19.6 percent to $9.53.
• Electromed, Inc. ELMD shares gained 19.3 percent to $6.56 following Q4 results. Electromed posted Q4 earnings of $0.13 per share on sales of $8.2 million.
• Oasmia Pharmaceutical AB OASM shares surged 13.8 percent to $5.29.
• Obalon Therapeutics, Inc. OBLN gained 12.5 percent to $2.88 after announcing approval of a Premarket Approval Supplement (PMA-S) application for the Obalon Touch™ Inflation System.
• Anavex Life Sciences Corp. AVXL surged 11.4 percent to $3.04.
• Vanda Pharmaceuticals Inc. VNDA rose 9.3 percent to $22.575. Vanda Pharmaceuticals will replace Inogen in the S&P SmallCap 600 on Monday, October 1.
• Canada Goose Holdings Inc GOOS rose 9.3 percent to $63.39 after DA Davidson initiated coverage on the stock with a Buy rating and $68 price target.
• AVEO Pharmaceuticals, Inc. AVEO gained 8.4 percent to $3.415.
• GoPro, Inc. GPRO shares rose 6.8 percent to $7.07. Oppenheimer upgraded GoPro from Perform to Outperform.
• Papa John's Int'l, Inc. PZZA rose 5.4 percent to $48.72 following Bloomberg report that the founder Is reaching out to PE firms related to a possible deal.
• Alexion Pharmaceuticals, Inc. ALXN rose 5.2 percent to $135.74 after the company earlier announced it will acquire Syntimmune for $400 million up front and up to $800 million in potential milestones.
• VAALCO Energy, Inc. EGY rose 4.3 percent to $2.70 after the company received a 10-year extension of three Exclusive Exploitation Authorizations under the Etame PSC.
• Verastem, Inc. VSTM rose 3.8 percent to $7.4201 after announcing the signing of an exclusive license agreement for the development and commercialization of COPIKTRA in China. The company will receive an upfront payment of $15 million and will be eligible for up to $30 million in milestones.
• AAR Corp. AIR rose 3.4 percent to $47.56 after reporting better-than-expected results for its first quarter.

Check out these big penny stock gainers and losers

Losers

• Level Brands, Inc. LEVB shares fell 24.3 percent to $3.975.
• Digital Ally, Inc. DGLY shares dipped 15.5 percent to $3.00. Digital Ally priced its 2.4 million share offering at $3.05 per share.
• Entasis Therapeutics Holdings Inc. ETTX shares declined 13.2 percent to $13.02. Entasis Therapeutics priced its upsized offering of 5 million shares at $15, below the estimated price range of $16 to $18.
• CPI Card Group Inc. PMTS shares fell 9.7 percent to $3.30.
• Pioneer Energy Services Corp. PES shares declined 9.6 percent to $3.075 after the company lowered its forecast for international drilling utilization.
• Aceto Corporation ACET dropped 9.2 percent to $2.57. Garrett Motion Inc. will replace Aceto in the S&P SmallCap 600 on Tuesday, October 2.
• PolarityTE, Inc PTE shares fell 8.6 percent to $19.30 as traders circulate negative comments from Capitol Forum. The firm said PolarityTE's form 483 raised issues with SkinTE processing.
• NextDecade Corporation NEXT shares declined 8.5 percent to $5.05.
• Worthington Industries, Inc. WOR shares fell 8.2 percent to $42.61 after the company missed Q1 earnings estimates.
• Nightstar Therapeutics plc NITE fell 8 percent to $18.81 after reporting a 4 million ADS offering.
• Chegg Inc CHGG dropped 7.9 percent to $29.80. The company late Tuesday reaffirmed Q3 sales guidance, which was near the lower end of estimates.
• Actuant Corporation ATU dropped 6.6 percent to $27.80. Actuant posted upbeat results for its fourth quarter, but issued a weak profit forecast.
• Cintas Corporation CTAS fell 5.3 percent to $201.8205. Cintas reported upbeat earnings for its first quarter and raised FY19 guidance.
• CyrusOne Inc. CONE fell 4.3 percent to $61.88. CyrusOne priced its 8 million shares offering at $62 per share.